FDA inspection
Amicogen (China) Biopharm Co., Ltd.: FDA inspection ending Mar 31, 2025
FDA inspection 1267049 · Official Action Indicated (OAI) · Jining
Key facts
| Inspection ID | 1267049 |
|---|---|
| Firm | Amicogen (China) Biopharm Co., Ltd. |
| FEI number | 3013147895 |
| Address | 1688 Shixian Road, Ren Cheng |
| City | Jining |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Mar 31, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data